Balance sheet of Mankind Pharma is strong.
It shouldn't have solvency or liquidity issues.

Yes, The debt of Mankind Pharma is increasing.
Latest debt of Mankind Pharma is -₹720.65 Crs as of Sep-24.
This is greater than Mar-24 when it was -₹2,199.17 Crs.

Yes, profit is increasing.
The profit of Mankind Pharma is ₹2,125 Crs for TTM, ₹1,913 Crs for Mar 2024 and ₹1,282 Crs for Mar 2023.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Mankind Pharma latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are allocated to majorly unproductive assets like Cash & Short Term Investments